MedAvail Holdings, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 11.27 million compared to USD 5.66 million a year ago. Revenue was USD 11.46 million compared to USD 5.79 million a year ago. Net loss was USD 11.81 million compared to USD 11.27 million a year ago. Basic loss per share from continuing operations was USD 7.5 compared to USD 17 a year ago. Diluted loss per share from continuing operations was USD 7.5 compared to USD 17 a year ago.
For the nine months, sales was USD 31.21 million compared to USD 14.17 million a year ago. Revenue was USD 31.76 million compared to USD 14.85 million a year ago. Net loss was USD 36.55 million compared to USD 31.19 million a year ago. Basic loss per share from continuing operations was USD 30 compared to USD 48 a year ago. Diluted loss per share from continuing operations was USD 30 compared to USD 48 a year ago.